Equities

Sincere Co Ltd

7782:TYO

Sincere Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)481.00
  • Today's Change-6.00 / -1.23%
  • Shares traded4.50k
  • 1 Year change-13.02%
  • Beta1.6669
Data delayed at least 20 minutes, as of May 22 2024 05:17 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sincere Co., LTD. is a Japan-based company mainly engaged in the production and sale of contact lenses. The Company operates through domestic and overseas two geographic segments. The main products are clear lens lenses, circle lenses and color contact lenses of one-day disposable, two-week and one-month types. The main brands include L-CON 1DAY, L-CON 1DAY EXCEED, 1day EYE WELL, L-CON 2WEEK UV, FAIRY and Miche Bloomin’ Monthly.

  • Revenue in JPY (TTM)5.90bn
  • Net income in JPY247.47m
  • Incorporated2008
  • Employees57.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
7782:TYO since
announced
Transaction
value
Talos Systems CorpAnnounced29 Feb 202429 Feb 2024Announced-6.60%2.44m
Talos Systems CorpDeal completed30 Nov 202330 Nov 2023Deal completed-8.73%2.52m
Data delayed at least 20 minutes, as of May 22 2024 05:17 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Dentas Co Ltd859.87m-43.41m1.24bn47.00------1.44-106.84-106.842,117.60-17.571.423.896.41---7.76-8.61-17.11-14.8431.0128.20-5.47-6.360.7503-7.420.9599---4.242.77-60.04--37.69--
Platz Co Ltd6.49bn274.18m2.78bn106.009.650.81128.120.429177.3777.371,830.46920.911.035.515.3461,193,490.004.375.756.188.3830.1236.304.235.012.26--0.372529.40-1.042.57-15.64-1.60-10.02-6.89
Sincere Co Ltd5.90bn247.47m3.34bn57.0012.531.2411.770.566438.8738.87926.66394.031.263.405.74103,506,200.005.433.988.455.5731.4129.464.322.691.83154.080.469537.896.737.34347.1879.5232.1747.58
KAWAMOTO CORPORATION29.63bn401.76m4.76bn444.0011.450.64968.800.160869.3269.325,112.851,222.321.528.753.14--2.094.034.027.7117.0717.791.382.371.37--0.434811.19-2.544.66-46.2541.6216.7435.10
Shigematsu Works Co Ltd13.00bn584.08m5.49bn384.009.290.65519.070.422782.1382.131,827.481,164.760.83042.334.24--3.734.085.466.6330.8031.174.494.571.12576.660.273715.030.92993.87-21.9465.709.264.56
Leoclan Co Ltd27.11bn375.99m5.50bn176.0014.680.988811.110.2029190.77190.7713,755.752,831.802.16535.095.21154,027,100.003.103.096.207.1611.0710.091.441.462.08--0.0018.56-10.530.7026-37.92-5.3819.25--
Kowa Co Ltd6.40bn710.43m6.48bn7.87k8.422.306.901.01153.77153.771,379.57563.731.282.757.56--14.506.0623.769.1046.1146.3711.295.390.974913.790.27522.992.167.1962.08---10.57--
Yamashita Health Care Holdings Inc61.84bn660.00m7.02bn570.0010.640.83628.140.1135258.51258.5124,234.433,288.822.5717.485.52108,496,500.002.721.947.505.6113.6311.821.060.70731.05--0.003635.555.53-0.1702-68.54-0.14623.4513.05
Koken Ltd10.04bn538.47m8.26bn287.0014.860.64668.190.8232108.96108.962,031.292,503.850.47272.222.6434,975,880.002.543.703.174.7545.5046.695.367.191.8819.130.33325.88-0.16054.92-15.8414.33-39.876.96
Create Medic Co Ltd12.69bn83.34m9.29bn962.00104.670.572413.450.73189.189.181,395.571,678.910.66781.734.3913,193,190.000.43853.000.51453.5343.6845.360.65674.602.98--0.050363.222.103.11-68.06-25.530.66271.12
DVx Inc45.85bn172.91m10.82bn319.0060.461.1417.890.23616.6116.614,394.81880.721.9826.604.02--0.74743.111.777.5710.3911.600.37711.491.51--0.001447.57-3.442.57-81.53-29.2311.2315.81
JMS Co Ltd65.29bn-36.00m13.33bn5.65k--0.32524.740.2042-1.49-1.492,668.181,657.260.82072.784.07---0.05781.33-0.08651.9721.5924.29-0.07051.570.987--0.397943.412.432.38-112.81---2.421.22
Data as of May 22 2024. Currency figures normalised to Sincere Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

0.92%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 30 Apr 202424.20k0.35%
Daiwa Asset Management Co. Ltd.as of 29 Mar 202414.40k0.21%
Nikko Asset Management Co., Ltd.as of 10 May 202411.80k0.17%
Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 20244.80k0.07%
BlackRock Japan Co. Ltd.as of 09 May 20242.40k0.04%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 20 Apr 20232.40k0.04%
Asset Management One Co., Ltd.as of 09 May 20241.50k0.02%
Amundi Asset Management SA (Investment Management)as of 08 May 2024589.000.01%
State Street Global Advisors (Japan) Co. Ltd.as of 06 Mar 2023400.000.01%
Norinchukin Zenkyoren Asset Management Co., Ltd.as of 09 May 2024300.000.00%
More ▼
Data from 30 Nov 2023 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.